Dr. Chris Gilligan and the team of ReActiv8-B investigators have been pivotal to establishing the emerging field of “Restorative Neurostimulation” for refractory chronic mechanical low back pain. In this publication, the researchers detail the randomized, sham-controlled, double-blinded ReActiv8-B trial to demonstrate safety and efficacy of a novel, implantable restorative-neurostimulator targeting functional instability of the lumbar spine in patients with refractory mechanical chronic low back pain. These 2-year patient outcome demonstrate long-term efficacy of ReActiv8 Restorative Neurostimulation.

Click here to download the publication free of charge.